Skip to main content
Ciulli Laboratory
School of Life Sciences, University of Dundee
Main menu
Home
Alessio Ciulli
Research
Group
Publications
Positions
Events
Contact
Home
Alessio Ciulli
Research
Targeted Protein Degradation: PROTACs
Cullin RING E3 Ubiquitin Ligases
Chromatin-Reader Domains
Fragment-Based Ligand Discovery
Chemical Probes
Group
Past Group Members
Past Group Photos
Ciulli Lab Cards
Group Achievements
Publications
Journal Club
Positions
Postdoctoral Scientists
Postgraduate Studentships
Visiting PhD Students
Summer studentships / Internships
Events
News
Symposium 2024
CeTPD Open Day
Contact
News
Symposium 2024
CeTPD Open Day
News
November 2022
UKRI and MRC Chairs visit our new CeTPD and meet with staff and students
Study raises hopes of preventing resistance in cancer therapy
October 2022
Discovery raises hopes of further anti-cancer breakthroughs
September 2022
Amphista therapeutics opens Cambridge's Granta Park research facility and is named “Fierce 15” Biotech Companies of 2022
August 2022
Research breakthrough will help develop future treatments against Parkinson’s disease
Now published in Chemical Society Reviews: Claudia & Alessio's review on VHL ligands and their use as VHL inhibitors and in PROTAC degraders
July 2022
Tag tech collaboration to battle undruggable diseases
SULSA funding success for early career researchers
May 2022
Drug Discovery Award for Alessio Ciulli
Amphista announces collaborations potentially worth $2 billion
Pages
« first
‹ prev
1
2
3
4
5
6
7
8
9
…
next ›
last »